Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

August 17, 2022

Study Completion Date

February 1, 2023

Conditions

Retinal Disease

Interventions

DRUG

Aflibercept (BAY86-5321, Eylea)

Intravitreal injection of aflibercept as scheduled by treating physician

Trial Locations (1)

Many locations, Multiple Locations